Home> Products> oral anticoagulant noac

{ "products": [ { "_id": "68beb194933ec7924333073c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PYRITIGMIN RIVA 1.5", "description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.", "price": 192.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2176, "imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:36:04.37Z", "updatedon": "2025-09-08T10:36:04.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rivastigmine 1.5 mg capsule", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e72553345171da8e569d1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 445.0, "discountamount": 133.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "Hair loss", "INR levels", "high levels", "Weight gain", "motor skills", "correct dose", "initial dose", "Liver damage", "Proper dosage", "effective use", "divided doses", "various types", "valproate ion", "valproic acid", "increased risk", "medical advice", "Concurrent use", "dosing syringe", "manic episodes", "close monitoring", "sodium valproate", "bipolar disorder", "Divalproex Sodium", "active ingredient", "Drug Interactions", "neuronal activity", "dosage adjustments", "Bleeding Disorders", "Regular monitoring", "migraine headaches", "low platelet count", "healthcare provider", "electrical activity", "Common side effects", "effective medication", "anticoagulant effect", "Migraine Prophylaxis", "various neurological", "liver function tests", "1:1 molar relationship", "psychiatric conditions", "potential side effects", "healthcare professional", "gamma-aminobutyric acid", "congenital malformations", "complex absence seizures", "complex partial seizures", "More severe side effects", "other antiepileptic drugs", "optimal clinical response", "administration instructions", "inhibitory neurotransmitter", "mood-stabilizing properties", "mood-stabilizing medication", "DIOWELPREX 250 ORAL SOLUTION", "stable coordination compound", "Gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1933, "imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:36:53.173Z", "updatedon": "2024-07-10T11:36:53.173Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-250-oral-solution-/1933", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX 250 ORAL SOLUTION ", "category": "NEUROLOGY RANGE", "tags": [ "Divalproex 250 mg", "Divalproex side effects", "Divalproex prolonged release tablets", "Divalproex extended release tablets IP 250 mg", "Divalproex prolonged release tablets uses", "Divalproex 250 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6fa253fc1c22985081c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 120 ", "description": "SLIM BOOST CTSTAT 120 \nCetilistat (120mg)\nIntroduction\nSLIM BOOST CTSTAT 120 is an advanced weight management medication containing Cetilistat (120mg), a potent oral lipase inhibitor aimed at aiding weight reduction in individuals struggling with obesity. By preventing the digestion and absorption of dietary fats, Cetilistat helps decrease caloric intake, facilitating weight loss when combined with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (120mg): A lipase inhibitor that specifically targets and inhibits gastrointestinal lipases, crucial enzymes for the digestion of fats.\nMechanism of Action\nCetilistat works by inhibiting the action of pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted in the feces, leading to reduced calorie absorption and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 120 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 120mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and alongside a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Following dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 120, with its active ingredient Cetilistat, provides an effective solution for managing obesity and supporting weight loss efforts. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Adhering to dietary recommendations and monitoring for any adverse effects will help achieve the best outcomes with SLIM BOOST CTSTAT 120.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "dietary fats", "risk factors", "best outcomes", "fecal urgency", "oily spotting", "fat absorption", "obese patients", "typical dosage", "Abdominal pain", "caloric intake", "adequate intake", "Concomitant use", "crucial enzymes", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "dietary guidelines", "fecal incontinence", "Obesity Management", "effective solution", "cyclosporine levels", "Overweight Patients", "weight loss efforts", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "potential side effects", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "reduced calorie absorption", "absorbable free fatty acids", "potent oral lipase inhibitor", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome", "advanced weight management medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1932, "imageuri": "https://productimages.withfloats.com/actual/68316fd9ab217a50d26b6b09.png", "tileimageuri": "https://productimages.withfloats.com/tile/68316fd9ab217a50d26b6b09.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:25:22.65Z", "updatedon": "2025-05-24T07:05:59.696Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-120-/1932", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cetilistat (120mg)", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat dosage", "Cetilistat side effects", "Cetilistat 120 mg side effects", "Cetilistat 120 mg brands in india", "Cetilistat 120 mg Uses in Hindi", "Cetilistat Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6cdd5c559a0c24bb221a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 60 ", "description": "SLIM BOOST CTSTAT 60 \nCetilistat (60mg)\nIntroduction\nSLIM BOOST CTSTAT 60 is a weight management medication containing Cetilistat (60mg), an oral lipase inhibitor designed to assist in weight reduction in individuals with obesity. By inhibiting the digestion and absorption of dietary fats, Cetilistat helps reduce caloric intake, promoting weight loss when used in conjunction with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (60mg): A novel lipase inhibitor that targets gastrointestinal lipases, crucial enzymes for fat digestion.\nMechanism of Action\nCetilistat works by inhibiting pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted, reducing the overall caloric intake and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 60 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 60mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and in conjunction with a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Adherence to dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 60, with its active ingredient Cetilistat, offers an effective solution for weight management in obese and overweight individuals. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Always adhere to dietary recommendations and monitor for any adverse effects to achieve the best outcomes with SLIM BOOST CTSTAT 60.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "risk factors", "dietary fats", "fat digestion", "best outcomes", "fecal urgency", "oily spotting", "obese patients", "fat absorption", "typical dosage", "Abdominal pain", "Concomitant use", "crucial enzymes", "adequate intake", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "Obesity Management", "dietary guidelines", "fecal incontinence", "effective solution", "cyclosporine levels", "Overweight Patients", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "oral lipase inhibitor", "overweight individuals", "overall caloric intake", "potential side effects", "novel lipase inhibitor", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "absorbable free fatty acids", "weight management medication", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1931, "imageuri": "https://productimages.withfloats.com/actual/668e6cdfa916e42e88302495.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e6cdfa916e42e88302495.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:13:33.226Z", "updatedon": "2024-07-10T11:13:33.226Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-60-/1931", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SLIM BOOST CTSTAT 60 ", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat 120 mg Uses in Hindi", "", "Cetilistat dosage", "Cetilistat Tablets", "Cetilistat Brand name", "Cetilistat side effects", "Cetilistat 120 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e670cc6d2d31770978860", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEFEXOTIME DICLOXA ", "description": "CEFEXOTIME DICLOXA \nCefixime (200mg), Dicloxacillin ER (500mg)\nIntroduction\nCEFEXOTIME DICLOXA is a potent antibiotic combination therapy that includes Cefixime (200mg) and Dicloxacillin ER (500mg). This medication is designed to combat a broad spectrum of bacterial infections, leveraging the synergistic effects of both antibiotics to enhance efficacy.\n\nComposition\n\nCefixime (200mg): A third-generation cephalosporin antibiotic known for its broad-spectrum activity against Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.\nDicloxacillin ER (500mg): An extended-release form of dicloxacillin, a penicillinase-resistant penicillin. It is particularly effective against penicillinase-producing staphylococci and works by inhibiting cell wall synthesis.\nMechanism of Action\n\nCefixime: It binds to penicillin-binding proteins (PBPs) within the bacterial cell wall, disrupting the cross-linking of peptidoglycan chains necessary for cell wall strength and rigidity, resulting in cell lysis.\nDicloxacillin: It similarly binds to PBPs, preventing the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, which is crucial for maintaining cell wall integrity.\nIndications\nCEFEXOTIME DICLOXA is indicated for the treatment of various bacterial infections, including:\n\nRespiratory tract infections (e.g., bronchitis, pneumonia)\nUrinary tract infections (UTIs)\nSkin and soft tissue infections\nOtitis media\nSinusitis\nBone and joint infections\nDosage and Administration\nThe typical dosage for adults is one tablet taken twice daily, with or without food. The duration of treatment depends on the severity and type of infection, usually ranging from 7 to 14 days. It is essential to complete the full course of therapy to prevent the development of antibiotic-resistant bacteria.\n\nSide Effects\nCommon side effects may include:\n\nGastrointestinal disturbances (nausea, vomiting, diarrhea)\nAllergic reactions (rash, itching, anaphylaxis in severe cases)\nPseudomembranous colitis\nHepatic dysfunction (elevated liver enzymes)\nHematologic effects (eosinophilia, neutropenia)\nRenal toxicity (in rare cases)\nPrecautions\n\nAllergy: Patients with a history of allergic reactions to cephalosporins, penicillins, or any other beta-lactam antibiotics should use this medication with caution.\nRenal Impairment: Dose adjustment may be necessary for patients with renal dysfunction.\nPregnancy and Lactation: The safety of this medication in pregnant and breastfeeding women has not been fully established. It should only be used if clearly needed and prescribed by a healthcare provider.\nDrug Interactions\n\nProbenecid: May increase blood levels of Cefixime.\nWarfarin: Concomitant use can enhance anticoagulant effects, increasing the risk of bleeding.\nMethotrexate: Cefixime may reduce renal clearance of methotrexate, increasing its toxicity.\nOral Contraceptives: Antibiotics may reduce the efficacy of oral contraceptives, suggesting the need for additional contraceptive measures.\nConclusion\nCEFEXOTIME DICLOXA, with its combination of Cefixime and Dicloxacillin, provides a robust treatment option for various bacterial infections. Its broad-spectrum efficacy, combined with the extended-release formulation, ensures a potent and convenient antibiotic therapy. As with all antibiotics, it is crucial to use this medication as prescribed and complete the full course to prevent the emergence of resistant bacteria and achieve optimal therapeutic outcomes. Always consult with a healthcare professional before starting any new medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 395.0, "discountamount": 118.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "rare cases", "one tablet", "cell lysis", "full course", "blood levels", "severe cases", "7 to 14 days", "Otitis media", "new medication", "Renal toxicity", "typical dosage", "broad spectrum", "renal clearance", "Concomitant use", "Dose adjustment", "Dicloxacillin ER", "Renal Impairment", "joint infections", "Drug Interactions", "renal dysfunction", "Allergic reactions", "CEFEXOTIME DICLOXA", "cell wall strength", "Oral Contraceptives", "healthcare provider", "breastfeeding women", "Hepatic dysfunction", "Hematologic effects", "synergistic effects", "Common side effects", "cell wall integrity", "peptidoglycan chains", "bacterial cell walls", "extended-release form", "anticoagulant effects", "Gram-negative bacteria", "soft tissue infections", "elevated liver enzymes", "broad-spectrum efficacy", "healthcare professional", "broad-spectrum activity", "peptidoglycan synthesis", "robust treatment option", "Pseudomembranous colitis", "Urinary tract infections", "penicillin-binding proteins", "final transpeptidation step", "Respiratory tract infections", "various bacterial infections", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "antibiotic-resistant bacteria", "other beta-lactam antibiotics", "convenient antibiotic therapy", "bacterial cell wall synthesis", "additional contraceptive measures", "penicillinase-resistant penicillin", "penicillinase-producing staphylococci", "potent antibiotic combination therapy", "third-generation cephalosporin antibiotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1928, "imageuri": "https://productimages.withfloats.com/actual/668e670f4e0af60ab3e5e128.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e670f4e0af60ab3e5e128.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T10:48:44.065Z", "updatedon": "2024-07-10T10:48:44.065Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefexotime-dicloxa-/1928", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEFEXOTIME DICLOXA ", "category": "GENERAL RANGE", "tags": [ "Cefixime and Dicloxacillin tablets Uses in Hindi", "Cefixime+Dicloxacillin er tablets", "", "Cefixime and Dicloxacillin uses", "Cefixime Dicloxacillin and lactic acid bacillus ta", "", "Cefixime + Dicloxacillin and Lactic acid bacillus ", "Cefixime Dicloxacillin mr and lactic acid bacillus", "Cefixime and Dicloxacillin tablets side effects", "Cefixime dicloxacillin tablet uses in tamil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac1c8d0d0330684bdbc69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 4 ", "description": "NICOMALOM 4 \nNicoumalone (4mg)\nIntroduction:\n\nNICOMALOM 4 contains Nicoumalone (4 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 4 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 4 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-4-133593", "price": 389.4, "discountamount": 116.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "4 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1862, "imageuri": "https://productimages.withfloats.com/actual/667d22cdba7e6420d2a5125f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d22cdba7e6420d2a5125f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:54:16.529Z", "updatedon": "2024-06-27T08:29:00.414Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-4-/1862", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 4 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 4 mg tablet price", "nicoumalone 4mg", "nicoumalone 1mg uses in hindi", "acitrom 4mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abf93396cee0250f91bbf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 3 ", "description": "NICOMALOM 3 \nNicoumalone (3mg)\nIntroduction:\n\nNICOMALOM 3 contains Nicoumalone (3 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 3 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 3 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-3-133592", "price": 359.4, "discountamount": 107.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "EMAIL", "water", "Doses", "heart", "tablet", "product", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "3 mg dosage", "information", "INR) levels", "Nicoumalone", "initial dose", "sterisonline", "Key Features", "sterispharma", "Introduction", "CALL/WHATSAPP", "long-term use", "Initial Dosage", "Administration", "prothrombin time", "most indications", "target INR range", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1861, "imageuri": "https://productimages.withfloats.com/actual/666abf968b71a2cb2d7d4e2d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abf968b71a2cb2d7d4e2d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:44:51.78Z", "updatedon": "2024-06-26T11:15:50.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-3-/1861", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 3 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 3mg uses", "nicoumalone side effects", "nicoumalone tablet uses in hindi", "nicoumalone contraindications", "nicoumalone tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 2 ", "description": "NICOMALOM 2 \nNicoumalone (2mg)\nIntroduction:\n\nNICOMALOM 2 contains Nicoumalone (2 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 2 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 2 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/nicomalom-2-133591", "price": 243.0, "discountamount": 72.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2024-06-26T11:13:41.928Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-2-/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }